Reduced expression of a novel peptide, prostacyclin-stimulating factor, in the kidneys of streptozotocin-induced diabetic rats

Journal of Diabetes and its Complications

Volumn 12, Issue 5, 1998, Pages 252-258

  Ono, Yasuhiro ^a   Umeda, Fumio ^a   Sekiguchi, Naotaka ^a   Hashimoto, Toshihiko ^a   Masakado, Mitsunori ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEPTIDE; PROSTACYCLIN; PROSTACYCLIN STIMULATING FACTOR; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTICLE; BRONCHUS MUSCLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULAR LESION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOLOGICAL FACTORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; MALE; RATS; RATS, WISTAR; REFERENCE VALUES;

EID: 0031669167     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00091-3     Document Type: Article

References (36)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 320:1983;977-986.
2. Krolewski A.S., Warram J.H., Christleib A.R., Busick E.J., Kahn C.R. The changing natural history of nephropathy in type 1 diabetes. Am J Med. 78:1985;785-794.
3. Edelstein D., Brownlee M. Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia. 35:1992;96-97.
4. Christensen N.J. Plasma catechomlamines in long-term diabetes with and without nephropathy and in hypophysectomized subjects. J Clin Invest. 51:1972;779-787.
5. Christlieb A.R., Kaldany A., D'Elia J.A. Plasma renin activity and hypertension in diabetes mellitus. Diabetes. 25:1976;969-974.
6. Craven P.A., DeRubertis F.R. Protein kinase C is activated in glomeruli from streptozotosin diabetic rats. J Clin Invest. 83:1989;1667-1675.
7. Moncada S., Vane J.R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 34:1978;129-135.
8. Moncada S. Biological importance of prostacyclin. Br J Pharmacol. 76:1982;3-31.
9. Inoguchi T., Umeda F., Ono H., Kunisaki M., Nawata H. Abnormality in prostacyclin-stimulatory activity in sera from diabetics. Metabolism. 38:1988;1561-1568.
10. Inoguchi T., Umeda F., Watanabe J., Ibayashi H. Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 3:1987;243-248.
11. Tajiri Y., Umeda F., Inoguchi T., Nawata H. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat. J Diabet Complications. 8:1994;126-132.
12. Yamauchi T., Umeda F., Masakado M., Ono Y., Nawata H. Serum-free conditioned medium of human diploid fibroblast cells contains an activity that stimulates prostacyclin production by cultured bovine aortic endothelial cells. Biochem Mol Biol Int. 1:1993;65-71.
13. Yamauchi T., Umeda F., Masakado M., Isaji M., Mizushima S., Nawata H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J. 303:1994;591-598.
14. Masakado M., Umada F., Yamauchi T., Ishii H., Ono Y., Nawara H. Human fibroblast cells produce a factor that stimulates prostacyclin synthesis by vascular endothelial cells. Thromb Res. 76:1994;513-524.
15. Ono Y., Hashimoto T., Umeda F., Masakado M., Isaji M., Mizushima S., Nawata H. Expression of prostacyclin-stimulating factor, a novel factor, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun. 202:1994;1490-1496.
16. Masakado M., Umenda F., Takei A., Hashimoto T., Sueishi K., Nawata H. Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues. Thromb Haemost. 74:1995;1407-1410.
17. Hsu S.M., Rain L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 29:1981;577-580.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenal-chloroform extraction. Anal Biochem. 162:1987;156-159.
19. Kawakami M., Ishibashi S., Ogawa H., Murase T., Takaku F., Shibata S. Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun. 141:1986;482-487.
20. Bhatia P., Taylor W.R., Greenberg H., Wright J.A. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for Northern blot analysis of cell lines of varying malignant potential. Anal Biochem. 216:1994;223-226.
21. Mauer S.M., Steffes M.W., Sutherland D.E., Najarian S., Michaer A.F., Brown D.M. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes. 24:1975;280-285.
22. Niwa T., Maeda K., Naotsuka Y., Asada H., Kobayashi M., Kawaguchi S., Shibata M. Improvement of renal function with prostaglandin E1 infusion in patients with chronic renal disease. Lancet. 1:1982;687.
23. Parving H.H., Anderson A.R., Smidt U.M., Svendsen P.A. Early aggressive hypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1:1983;1175-1179.
24. Mogensen C.E., Christiansen C.K., Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy Diabetes. 32:1983;64-78.
25. Palmisano J.J., Lebovitz H.E. Renal function in black Americans with type II diabetes. J Diabet Complications. 3:1989;40-44.
26. 2 excretion in diabetes mellitus. J Lab Clin Med. 109:1979;711-717.
27. 2 in experimental diabetes mellitus. J Lab Clin Med. 108:1986;332-339.
28. Tajiri Y., Inoguchi T., Umeda F., Nawata H. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy. Diabetes Res Clin Pract. 10:1990;231-239.
29. Kreisberg J.I., Patel P.Y. the effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukot Med. 11:1983;431-442.
30. Schambelan M., Blake S., Sraer J., Bens M., Nivez M.P., Wahbe F. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 75:1985;404-412.
31. Craven P.A., Caines M.A., DeRubertis F.R. Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats. Relationship to the hyperfiltration of early diabetes Metabolism. 36:1987;95-103.
32. DeRubertis F.R., Craven P.A. Eicosanoids in the pathogenesis of the functional and structural alterations of kidney in diabetes. Am J Kid Dis. 22:1993;727-735.
33. Johnson M., Reece A.H., Harrison H.E. An imbalance in arachidonic acid metabolism in diabetes. Adv Prostaglandin Thromboxane Leukot Res. 8:1980;1283-1286.
34. Harrison H.E., Reece A.H., Johnson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci. 23:1978;351-355.
35. Silberbauer K., Schnernthaner A., Sinzinger H., Piza-Katzer H., Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes [Letter]. N Engl J Med. 300:1979;366-367.
36. Sekiguchi N., Umeda F., Masakado M., Ono Y., Hashimoto T., Nawata H. Immunochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic coronary artery. Diabetes. 46:1997;1627-1632.